-+ 0.00%
-+ 0.00%
-+ 0.00%

Curis Inc. Announces New Clinical Study of Emavusertib in Combination with BTK Inhibitor for Chronic Lymphocytic Leukemia

Reuters·08/05/2025 12:07:54

Please log in to view news